EUVIMEDTutustu EUVIMEDiin
Multizentrische StudieRandomisierte kontrollierte StudieOpen access · CC BY 4.0

The ILEOSTIM trial: A multicentre randomised controlled trial evaluating the impact of efferent loop stimulation prior to ileostomy reversal on postoperative ileus

Jorge Arredondo, Adriana Uriz iD, Irene Oliva, José I Martín, Christian N Iglesias iD, Ekta Choolani, Ainhoa Valle, Javier Rivera, Sebastián Jerí-McFarlane, Juan M Romero, Carolina González, Alicia Alvarellos and 11 more

Colorectal Disease · 2026-05 · 28 (5)

DOI: 10.1111/codi.70448 ↗

At a glance

Multizentrische Studie in Colorectal Disease, published online on 2026-05-06. Written by Jorge Arredondo and 22 co-authors. Institution: Department of General Surgery, Clínica Universidad de Navarra, Pamplona, Spain. Major MEDLINE topics: Ileostomy, Ileum, Ileus, Low Anterior Resection Syndrome. Cited 1 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0).

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

Strategies to optimise bowel function before stoma reversal surgery (SRS) are needed to improve postoperative outcomes. Efferent bowel stimulation (EBS) prior to stoma closure has been proposed as a potential strategy to reduce postoperative ileus (POI) incidence and improve the patient's postoperative course.

Methods

A multicentre randomised controlled trial was designed to evaluate the effectiveness of pre‐SRS EBS in reducing POI incidence. Patients scheduled for elective SRS were randomised 1:1 to either an intervention group, receiving daily EBS with saline and a nutritional thickener for 2 weeks preoperatively, or a control group, undergoing SRS without stimulation. The primary endpoint was POI incidence. Secondary outcomes included the time to oral diet tolerance, passage of first flatus/stool, surgery‐related comorbidities, length of hospital stay and incidence of Low Anterior Resection Syndrome (LARS) (NCT05302557‐31/03/2022).

Results

From June 2021 to April 2023, 175 patients were enrolled from 18 hospitals in Spain, 78 (44.5%) and 97 (55.4%) of whom were allocated to the intervention and control groups, respectively. We found that EBS was not significantly associated with a decrease in POI incidence (7.6% vs. 16.4%, p = 0.088). No significant differences in the median hospital stay ( p = 0.545) or LARS at discharge ( p = 0.087) were observed between the two groups. The EBS group showed fewer but more severe complications ( p = 0.015).

Conclusion

Preoperative EBS is a feasible and reproducible intervention that may represent a potential strategy to reduce POI following SRS.

Subjects

MeSH terms (MEDLINE)

IleostomyIleumIleusLow Anterior Resection SyndromePostoperative ComplicationsPreoperative CareAgedAged, 80 and overFemaleHumansMaleMiddle AgedElective Surgical ProceduresIncidenceLength of StayRectal NeoplasmsSaline SolutionSpainTherapeutic IrrigationTime FactorsTreatment Outcome

Author keywords

bowel stimulationileostomy reversalloop ileostomy closurepostoperative ileus

Substances

Saline Solution

Authors and institutions

  • Department of General Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
  • Department of General Surgery, Hospital Universitario de León, León, Spain.
  • Department of General Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Department of General Surgery, Hospital Universitario de Cabueñes, Gijón, Spain.
  • Department of General Surgery, Hospital Universitario Río Hortega, Valladolid, Spain.
  • Department of General Surgery, Hospital Universitario de Getafe, Madrid, Spain.

ORCID profiles: Adriana Uriz, Christian N Iglesias, Jeancarlos Trujillo-Díaz

Cite

APA

Arredondo, J., Uriz, A., Oliva, I., Martín, J. I., Iglesias, C. N., Choolani, E., Valle, A., Rivera, J., Jerí-McFarlane, S., Romero, J. M., González, C., Alvarellos, A., Tasende, M., Gómez, L., Lázaro, L., Montcusí, B., Tejedor, P., Trujillo-Díaz, J., de la Hermosa, A. R., …, & ILEOSTIM Trial Group (2026). The ILEOSTIM trial: A multicentre randomised controlled trial evaluating the impact of efferent loop stimulation prior to ileostomy reversal on postoperative ileus. Colorectal Disease, 28(5). https://doi.org/10.1111/codi.70448

Vancouver

Arredondo J, Uriz A, Oliva I, Martín JI, Iglesias CN, Choolani E, et al. The ILEOSTIM trial: A multicentre randomised controlled trial evaluating the impact of efferent loop stimulation prior to ileostomy reversal on postoperative ileus. Colorectal Disease. 2026;28(5). doi:10.1111/codi.70448

BibTeX
@article{Arredondo2026,
  author = {Arredondo, Jorge and Uriz, Adriana and Oliva, Irene and Martín, José I and Iglesias, Christian N and Choolani, Ekta and Valle, Ainhoa and Rivera, Javier and Jerí-McFarlane, Sebastián and Romero, Juan M and González, Carolina and Alvarellos, Alicia and Tasende, Marta and Gómez, Lourdes and Lázaro, Laura and Montcusí, Blanca and Tejedor, Patricia and Trujillo-Díaz, Jeancarlos and de la Hermosa, Alicia Ruiz and Baixauli, Jorge and Núñez-Córdoba, Jorge M and Aliseda, Daniel and ILEOSTIM Trial Group, ILEOSTIM Trial Group},
  title = {The ILEOSTIM trial: A multicentre randomised controlled trial evaluating the impact of efferent loop stimulation prior to ileostomy reversal on postoperative ileus},
  journal = {Colorectal Disease},
  year = {2026},
  volume = {28},
  number = {5},
  doi = {10.1111/codi.70448}
}
Start for free →